Home Newsfeeds JP Morgan Reiterates Overweight on Uber Technologies, Maintains $52 Price Target

JP Morgan Reiterates Overweight on Uber Technologies, Maintains $52 Price Target

JP Morgan analyst Doug Anmuth reiterates Uber Technologies (NYSE:UBER) with a Overweight and maintains $52 price target.

byBenzinga Newsdesk

February 9, 2023

1 minute read

JP Morgan analyst Doug Anmuth reiterates Uber Technologies (NYSE:UBER) with a Overweight and maintains $52 price target.

Wells Fargo Maintains Equal-Weight on FS KKR Capital, Raises Price Target to $18.5

By Benzinga Newsdesk

November 9, 10:05 AM

Wells Fargo analyst Finian O'Shea maintains FS KKR Capital (NYSE:FSK) with a Equal-Weight and raises the price target from $18 to $18.5.

FSK

Legal
News

Reported Late Wednesday April 5, DynaEnergetics, A Business Of DMC Global Inc. Successfully Defends Itself In Patent Infringement Case; Product Did Not Infringe On The 035 Patent, And No Damages Were Awarded

By Happy Mohamed

April 6, 12:31 AM

DynaEnergetics, a business of DMC Global Inc. (NASDAQ:BOOM) today announced it has successfully defended itself in an alleged infringement of Patent No. 9,810,035 ("035 patent"). The case was brought by

BOOM

Orchestra BioMed, Vital Farms And Other Big Stocks Moving Higher On Tuesday

By Lisa Levin

September 19, 10:43 AM

U.S. stocks traded lower on Tuesday. Here are some big stocks recording gains in today’s session.

ARRY

Mirion Technologies Q2 EPS $0.13 Beats $0.12 Estimate, Sales $175.80M Miss $181.12M Estimate

By Bill Haddad

July 29, 7:21 AM

Mirion Technologies (NYSE:MIR) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.12 by 8.33 percent. The company reported quarterly sales of $175.80 million which missed the

MIR

JP Morgan Reiterates Overweight on Uber Technologies, Maintains $52 Price Target

Related Posts

Wells Fargo Maintains Equal-Weight on FS KKR Capital, Raises Price Target to $18.5

Reported Late Wednesday April 5, DynaEnergetics, A Business Of DMC Global Inc. Successfully Defends Itself In Patent Infringement Case; Product Did Not Infringe On The 035 Patent, And No Damages Were Awarded

Orchestra BioMed, Vital Farms And Other Big Stocks Moving Higher On Tuesday

Mirion Technologies Q2 EPS $0.13 Beats $0.12 Estimate, Sales $175.80M Miss $181.12M Estimate